EW
HOLD / NEUTRALMeanRevComposite
54.00
Technical
45.50
Fundamental
56.80
Rank
—
Price
86.07
Hurst
0.08
As of
Aug 3, 2026
Daily
Edwards Lifesciences Corporation
HealthcareMedical DevicesEdwards Lifesciences develops and sells medical devices for treating cardiovascular diseases, operating in markets across the United States, Europe, Japan, and other regions. The company's product portfolio includes catheter-based valve systems for minimally invasive aortic, mitral, and tricuspid valve procedures, branded under SAPIEN, PASCAL, and EVOQUE, as well as surgical valve solutions such as INSPIRIS and related tissue valve products for complex cardiac repairs. Distribution occurs through its own sales team and third-party distributors.
Market cap
$53.0B
P/E (trailing)
54.77
P/E (forward)
27.21
PEG ratio
1.93
Dividend yield
0.00%
Beta
0.86
52w range
74.66 – 96.29
Return on equity
+9.18%
Profit margin
+15.43%
Revenue growth
+13.60%
Earnings growth
-25.40%
Price history
1Y: 92.01 (+11.6%) · range 75.87–95.18
Cycle position
64/ 100 cycle scoreAPPROACHING EXIT
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 14 · NOT READY · exit proximity 0
Conviction
26/ 100 · maturity 0%
Buildup.3318
EMA entry setup.4214
Fundamentals.2557
Volume profile
POC
86.63
Price vs POC
+6.2%
Overhead supply
10%
Runway
open sky
Value area 84.93–91.74 · 10% of 120d volume overhead · clean runway
Contributing sources
No source detections in the last 21 days.
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +2.17% | +5.45% | mature |
| 40d | -0.83% | +5.45% | mature |